Lv5
820 积分 2023-04-11 加入
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
2天前
已完结
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
28天前
已完结
POD24 in follicular lymphoma: time to be “wise”
1个月前
已关闭
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
1个月前
已完结
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
1个月前
已完结
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
1个月前
已关闭
Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival
2个月前
已关闭
Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma
2个月前
已完结
Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
2个月前
已完结
Prognostic value of the albumin-bilirubin score in patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis
2个月前
已完结
皖公网安备34019202002308
